[
  {
    "ts": "2026-01-22T06:03:30+00:00",
    "headline": "Vaccine makers feel a chill as US Health Secretary Kennedy's rhetoric becomes reality",
    "summary": "The unprecedented changes have led to diminished vaccine usage, hurt the investment case for some biotechs, and created a ‌drag that will likely dent revenues and raise costs for companies in the coming years, 15 investors and analysts told Reuters.",
    "url": "https://finance.yahoo.com/news/vaccine-makers-feel-chill-us-060330763.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "b058023d-98a0-30d2-9505-759b3108ff8d",
      "content": {
        "id": "b058023d-98a0-30d2-9505-759b3108ff8d",
        "contentType": "STORY",
        "title": "Vaccine makers feel a chill as US Health Secretary Kennedy's rhetoric becomes reality",
        "description": "",
        "summary": "The unprecedented changes have led to diminished vaccine usage, hurt the investment case for some biotechs, and created a ‌drag that will likely dent revenues and raise costs for companies in the coming years, 15 investors and analysts told Reuters.",
        "pubDate": "2026-01-22T06:03:30Z",
        "displayTime": "2026-01-22T06:03:30Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/1c54fd957ecc08ee53dfbb48ad3dd888",
          "originalWidth": 800,
          "originalHeight": 534,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EuBRqDuDSPNrtoA3GBOGSg--~B/aD01MzQ7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/1c54fd957ecc08ee53dfbb48ad3dd888.cf.webp",
              "width": 800,
              "height": 534,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pFdbe6h5J3wm8QCnJ9FMPw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/1c54fd957ecc08ee53dfbb48ad3dd888.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/vaccine-makers-feel-chill-us-060330763.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/vaccine-makers-feel-chill-us-060330763.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SNY"
            },
            {
              "symbol": "GLAXF"
            },
            {
              "symbol": "GSK"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "NVAX"
            },
            {
              "symbol": "BNTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]